Capital Fund Management S.A. Takes Position in Privia Health Group, Inc. $PRVA

Capital Fund Management S.A. bought a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 28,510 shares of the company’s stock, valued at approximately $656,000.

Several other hedge funds have also recently bought and sold shares of PRVA. Avantax Advisory Services Inc. grew its stake in Privia Health Group by 19.7% during the first quarter. Avantax Advisory Services Inc. now owns 15,039 shares of the company’s stock worth $338,000 after buying an additional 2,474 shares during the period. Cetera Investment Advisers lifted its holdings in shares of Privia Health Group by 3.9% during the 1st quarter. Cetera Investment Advisers now owns 61,936 shares of the company’s stock valued at $1,390,000 after acquiring an additional 2,338 shares in the last quarter. Federated Hermes Inc. boosted its position in Privia Health Group by 19.3% during the 1st quarter. Federated Hermes Inc. now owns 29,728 shares of the company’s stock worth $667,000 after purchasing an additional 4,804 shares during the period. Natixis Advisors LLC increased its holdings in Privia Health Group by 15.2% in the 1st quarter. Natixis Advisors LLC now owns 17,751 shares of the company’s stock valued at $399,000 after purchasing an additional 2,342 shares in the last quarter. Finally, US Bancorp DE increased its holdings in Privia Health Group by 2.4% in the 1st quarter. US Bancorp DE now owns 18,487 shares of the company’s stock valued at $415,000 after purchasing an additional 429 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have commented on PRVA. Barclays boosted their price objective on Privia Health Group from $22.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Monday, November 10th. Citizens Jmp boosted their price target on Privia Health Group from $30.00 to $31.00 and gave the stock a “market outperform” rating in a research report on Friday, November 7th. Canaccord Genuity Group upped their price target on Privia Health Group from $32.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, November 12th. Weiss Ratings reiterated a “hold (c)” rating on shares of Privia Health Group in a research note on Monday. Finally, JPMorgan Chase & Co. boosted their target price on shares of Privia Health Group from $32.00 to $33.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $30.00.

Privia Health Group Stock Down 0.7%

Shares of NASDAQ PRVA opened at $23.84 on Friday. Privia Health Group, Inc. has a fifty-two week low of $18.77 and a fifty-two week high of $26.51. The business has a 50 day moving average price of $24.47 and a two-hundred day moving average price of $22.77. The firm has a market cap of $2.93 billion, a PE ratio of 183.40, a price-to-earnings-growth ratio of 4.00 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last released its earnings results on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%.The company had revenue of $213.61 million during the quarter. On average, analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.